Oil prices rose back above $70 a barrel on Monday, with U.S. crude posting its best one-day dollar gain in over a month, after four weeks of losses for the benchmark.
U.S. West Texas Intermediate crude ended Monday's session up $1.44, or 2.1 percent, to $70.13 a barrel. While the contract has risen in seven of the last previous 10 sessions, it has not posted a gain of more than $1 a barrel since June 27.
As of Friday, WTI was down more than 7 percent over the last four weeks, as heavy losses in a handful of trading sessions wiped out a string of modest daily gains for the benchmark.
The contract to deliver international benchmark Brent crude for September was up 83 cents, or 1.1 percent, at $75.12 a barrel by 2:08 p.m. ET. The September contract expires on Tuesday. Trading was heavier for the October contract, which is up 97 cents, or 1.3 percent, at $75.73.
Top Oil Stocks To Watch Right Now: RELX N.V.(RENX)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on Relx (RENX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Relx (NYSE:RENX) was upgraded by research analysts at Barclays to a “buy” rating in a report released on Monday.
RENX has been the subject of several other research reports. Zacks Investment Research raised shares of Relx from a “sell” rating to a “hold” rating in a report on Thursday, August 16th. UBS Group cut shares of Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $23.00.
Top Oil Stocks To Watch Right Now: Valeant Pharmaceuticals International Inc(VRX)
Advisors' Opinion:- [By ]
Other recent false "tells" of "unusual call activity" have included Lowe's (LOW) , Valeant Pharmaceuticals (VRX) , Walmart (WMT) and Walt Disney Co. (DIS) . All of these stocks tanked within one or two weeks of the unusual call trading.
- [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Valeant Pharmaceuticals Intl (VRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Keith Speights]
Believe it or not, one of the best-performing healthcare stocks so far this year is none other than Valeant Pharmaceuticals International (NYSE:VRX). Longtime loser Valeant is up around 20% year to date -- much better than most healthcare stocks.
- [By Garrett Baldwin] President Trump will announce today if he will pull the United States out of the Obama-era nuclear deal. Trump wants European members of the treaty to amend certain issues regarding Iran's uranium enrichment capacity. Energy stocks and oil prices had been rising on speculation that Trump would slap Iran again with economic sanctions, disrupting the region's oil production. Comcast Corp. (Nasdaq: CMCSA) is currently working to obtain enough capital to purchase certain assets of Twenty-First Century Fox Inc. (NYSE: FOXA). The ability to raise capital would allow Comcast to replace Disney's $52 billion bid for the many of Fox's key businesses. Markets are reacting to a speech made this morning by U.S. Federal Reserve Chair Jerome Powell. During a speech in Zurich, Switzerland, Powell said that rising U.S. interest rates would not have a significant impact on emerging markets and foreign stock markets. This has long been a concern for other nations as the U.S. dollar rises and American bonds become more attractive to international investors. Four Stocks to Watch Today: DIS, C, SNAP The Walt Disney Co. (NYSE: DIS) will lead another busy day of earnings reports today. Investors will be exploring the impact of recent price hikes at the company's theme parks, as well as the ongoing concerns about cable cutting and how this trend affects ESPN. Markets anticipate that the company will report earnings per share of $1.68 on top of $14.23 billion in revenue. Shares of Citigroup Inc. (NYSE: C) are on the move. The uptick came after activist investor ValueAct announced a $1.2 billion stake in the investment bank. Citigroup shares were up 1.2% in pre-market hours. Shares of Snap Inc. (NYSE: SNAP) gained 1% in pre-market hours. The owner of social media giant Snapchat said that its CFO Drew Vollero will step down next week. The executive will be replaced by a financial executive at Amazon.com Inc. (Nasdaq: AMZN). Snap continues to face incredible pressures after the f
Top Oil Stocks To Watch Right Now: Eastman Kodak Company(KODK)
Advisors' Opinion:- [By William Patalon III]
I'd been covering the corporate flailing of the once-great Eastman Kodak Co. (NYSE: KODK) for nearly five years – a journalistic vision quest that took me from Upstate New York to Silicon Valley, Hollywood, Japan, and even China.
- [By ]
Eastman Kodak Co. (KODK) has accused Hong Kong-based trading exchange LBank.io of fraud related to its upcoming KODAKCoin initial coin offering (ICO). LBank.io claimed it would be hosting the KODAKCoin ICO from May 4 through May 11, but Kodak said it's not true. "It has come to our attention that more than one fraudulent website has been promoting the sale of KODAKCoin. All factual information regarding the availability of an IOC to accredited investors will come directly from KODAKCoin and its authorized representatives," Kodak said to Coindesk. Kodak had initially expected to begin offering its KODAKCoin in January, but has since delayed the sale. LBank.io is the ninth-largest cryptocurrency exchange in the world by trading volume.
- [By ]
Eastman Kodak Co. (NYSE:KODK) surprised investors earlier this month when the company announced it was planning to launch its own cryptocurrency.
Speculators quickly scooped up Kodak's languishing stock on the news, sending shares from $3 to more than $13 in just two trading days.
- [By Nicholas Rossolillo]
At the beginning of 2018, shares of Eastman Kodak (NYSE:KODK) surged from $3 to over $13 on news released at the Consumer Electronics Show that the company was working on its own cryptocurrency: KODAKCoin. Optimism has since faded as the coin offering and supporting platform have been postponed until summer 2019, and focus on the company's struggling financial results has resumed. As a result, the stock is back to plumbing new lows.
No comments:
Post a Comment